Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Family physicians' continuing professional development activities: current practices and potential for new options.

Lindsay E, Wooltorton E, Hendry P, Williams K, Wells G.

Can Med Educ J. 2016 Mar 31;7(1):e38-46. eCollection 2016.

2.

Striving for excellence: developing a framework for the Triple C curriculum in family medicine education.

MacDonald CJ, McKeen M, Wooltorton E, Boucher F, Lemelin J, Leith-Gudbranson D, Viner G, Pullen J.

Can Fam Physician. 2012 Oct;58(10):e555-62.

3.

Diabetes drug pioglitazone (Actos): risk of fracture.

Meymeh RH, Wooltorton E.

CMAJ. 2007 Sep 25;177(7):723-4. Epub 2007 Sep 6. No abstract available.

4.

Patient information about HPV and the HPV vaccine.

van Zyl T, Wooltorton E, MacDonald N.

CMAJ. 2007 Aug 28;177(5):462. No abstract available.

5.

Congratulations to our colleagues at Open Medicine.

Stanbrook MB, Flegel K, Sibbald B, Wooltorton E, McDonald N, Attaran A, H├ębert PC.

CMAJ. 2007 Jul 3;177(1):59-61. Review. No abstract available.

6.

Triptan migraine treatments and antidepressants: risk of serotonin syndrome.

Wooltorton E.

CMAJ. 2006 Oct 10;175(8):874. Epub 2006 Sep 20. No abstract available.

7.

Visual loss with erectile dysfunction medications.

Wooltorton E.

CMAJ. 2006 Aug 15;175(4):355. Epub 2006 Jul 26. No abstract available.

8.

Osteoporosis treatment: raloxifene (Evista) and stroke mortality.

Wooltorton E.

CMAJ. 2006 Jul 18;175(2):147. Epub 2006 Jun 27. No abstract available.

9.

Medications for attention deficit hyperactivity disorder: cardiovascular concerns.

Wooltorton E.

CMAJ. 2006 Jul 4;175(1):29. Epub 2006 Jun 13. No abstract available.

10.

Persistent pulmonary hypertension of the newborn and maternal use of SSRIs.

Wooltorton E.

CMAJ. 2006 May 23;174(11):1555-6. Epub 2006 May 2. No abstract available.

11.

People with diabetes should avoid antibiotic gatifloxacin.

Kendall C, Wooltorton E.

CMAJ. 2006 Apr 11;174(8):1089-90. Epub 2006 Mar 22. No abstract available.

12.

A catalyst for change.

Choi S, Flegel K, Kendall C, Palepu A, Wooltorton E, Murray S, Barrowman N.

CMAJ. 2006 Mar 28;174(7):901, 903. Epub 2006 Feb 24. English, French. No abstract available.

13.

WinRho and disseminated intravascular coagulopathy.

Kendall C, Wooltorton E.

CMAJ. 2006 Mar 14;174(6):767-8. Epub 2006 Feb 22. No abstract available.

14.

Rosiglitazone (Avandia) and macular edema.

Kendall C, Wooltorton E.

CMAJ. 2006 Feb 28;174(5):623. Epub 2006 Feb 8. No abstract available.

15.

The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns.

Wooltorton E.

CMAJ. 2006 Jan 17;174(2):164-5. Epub 2005 Dec 20. No abstract available. Erratum in: CMAJ. 2008 Jun 17;178(13):1688. Dosage error in article text.

16.

Suicidal ideation among children taking atomoxetine (Strattera).

Wooltorton E.

CMAJ. 2005 Dec 6;173(12):1447. No abstract available.

17.

Is the timing of infant cereal introduction a risk factor for celiac disease autoimmunity?

Belanger JE, Wooltorton E.

CMAJ. 2005 Nov 22;173(11):1324. No abstract available.

18.

Paroxetine (Paxil) and congenital malformations.

Williams M, Wooltorton E.

CMAJ. 2005 Nov 22;173(11):1320-1. Epub 2005 Nov 4. No abstract available.

19.

Long-acting beta2-agonists in asthma: safety concerns.

Wooltorton E.

CMAJ. 2005 Oct 25;173(9):1030-1. Epub 2005 Oct 7. No abstract available.

20.

Alcohol-associated rapid release of a long-acting opioid.

Murray S, Wooltorton E.

CMAJ. 2005 Sep 27;173(7):756. Epub 2005 Sep 8. No abstract available.

21.

The Canadian Hypertension Education Program (CHEP) recommendations: launching a new series.

McAlister FA, Wooltorton E, Campbell NR; Canadian Hypertension Education Program.

CMAJ. 2005 Aug 30;173(5):508-9. No abstract available.

22.

Septic shock after medical abortions with mifepristone (Mifeprex, RU 486) and misoprostol.

Murray S, Wooltorton E.

CMAJ. 2005 Aug 30;173(5):485. Epub 2005 Aug 10. No abstract available.

23.

Increased mortality among elderly patients with dementia using atypical antipsychotics.

Singh S, Wooltorton E.

CMAJ. 2005 Aug 2;173(3):252. Epub 2005 Jul 13. No abstract available.

24.

Serious allergic reactions following tuberculin skin tests.

Youssef E, Wooltorton E.

CMAJ. 2005 Jul 5;173(1):34. Epub 2005 Jun 15. No abstract available.

25.

Patients receiving intravenous bisphosphonates should avoid invasive dental procedures.

Wooltorton E.

CMAJ. 2005 Jun 21;172(13):1684. Epub 2005 Jun 1. No abstract available.

26.

Earlier clinical conundrum resolved: a diagnosis with teeth.

Wooltorton E.

CMAJ. 2005 May 24;172(11):1437. No abstract available.

27.

New restrictions on celecoxib (Celebrex) use and the withdrawal of valdecoxib (Bextra).

Cotter J, Wooltorton E.

CMAJ. 2005 May 10;172(10):1299. Epub 2005 Apr 15. No abstract available.

28.

Eczema drugs tacrolimus (Protopic) and pimecrolimus (Elidel): cancer concerns.

Wooltorton E.

CMAJ. 2005 Apr 26;172(9):1179-80. Epub 2005 Apr 7. No abstract available.

29.

Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss.

Wooltorton E.

CMAJ. 2005 Mar 15;172(6):746. Epub 2005 Mar 2. No abstract available.

30.

Medical gels and the risk of serious infection.

Wooltorton E.

CMAJ. 2004 Nov 23;171(11):1348. No abstract available.

31.

Infliximab and serious hematologic events.

Phelan C, Wooltorton E.

CMAJ. 2004 Oct 26;171(9):1045. No abstract available.

32.

Several Chinese herbal products may contain toxic aristolochic acid.

Wooltorton E.

CMAJ. 2004 Aug 31;171(5):449. No abstract available.

33.

Tips for learning and teaching evidence-based medicine: introduction to the series.

Wyer PC, Keitz S, Hatala R, Hayward R, Barratt A, Montori V, Wooltorton E, Guyatt G.

CMAJ. 2004 Aug 17;171(4):347-8. No abstract available.

34.

Rosuvastatin (Crestor) and rhabdomyolysis.

Wooltorton E.

CMAJ. 2004 Jul 20;171(2):129. No abstract available.

35.

A call for video images: medicine in real time.

Wooltorton E.

CMAJ. 2004 Jun 22;170(13):1931. No abstract available.

36.
37.

Asthma drug zafirlukast (Accolate): serious hepatic events.

Wooltorton E.

CMAJ. 2004 May 25;170(11):1668. No abstract available.

38.

Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials.

Wooltorton E.

CMAJ. 2004 Apr 27;170(9):1395. No abstract available.

39.

HIV drug nevirapine (Viramune): risk of severe hepatotoxicity.

Wooltorton E.

CMAJ. 2004 Mar 30;170(7):1091. No abstract available.

40.

Oseltamivir (Tamiflu) unsafe in infants under 1 year old.

Wooltorton E.

CMAJ. 2004 Feb 3;170(3):336. No abstract available.

41.

Paroxetine (Paxil, Seroxat): increased risk of suicide in pediatric patients.

Wooltorton E.

CMAJ. 2003 Sep 2;169(5):446. No abstract available.

42.

Combination hormone replacement therapy and dementia.

Wooltorton E.

CMAJ. 2003 Jul 22;169(2):133. No abstract available.

43.

Too much of a good thing? Toxic effects of vitamin and mineral supplements.

Wooltorton E.

CMAJ. 2003 Jul 8;169(1):47-8. Review. No abstract available. Erratum in: CMAJ. 2003 Aug 19;169(4):283.

44.

Concerns over lindane treatment for scabies and lice.

Wooltorton E.

CMAJ. 2003 May 27;168(11):1447-8. No abstract available.

45.

Risk of stroke, gangrene from ergot drug interactions.

Wooltorton E.

CMAJ. 2003 Apr 15;168(8):1015. No abstract available.

46.

Salmeterol (Serevent) asthma trial halted early.

Wooltorton E.

CMAJ. 2003 Mar 18;168(6):738. Review. No abstract available.

47.

Noninvasive treatments for umbilical granulomas.

Wooltorton E.

Am Fam Physician. 2003 Feb 15;67(4):698; author reply 698, 700. No abstract available.

48.

Diane-35 (cyproterone acetate): safety concerns.

Wooltorton E.

CMAJ. 2003 Feb 18;168(4):455-6. No abstract available.

49.

Accutane (isotretinoin) and psychiatric adverse effects.

Wooltorton E.

CMAJ. 2003 Jan 7;168(1):66. Review. No abstract available.

50.

Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials.

Wooltorton E.

CMAJ. 2002 Nov 26;167(11):1269-70. No abstract available.

Supplemental Content

Loading ...
Support Center